Long-term follow-up of serous ovarian tumors of low malignant potential

Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk

“…The studies included 2624 patients with serous borderline ovarian tumour (sBOT), 2120 patients with mucinous borderline ovarian tumour (mBOT) 165 other types of BOT (endometrioid, mixed, clear cell tumours and unspecified subtypes, ( Table 2). Of these studies, seven included only patients with sBOT [1,7,10,11] (four of which included only late-stage sBOT [12][13][14][15]), and two included only mBOT [16,17]. Regarding the presence of implants, 18 studies mentioned the presence and type of implants, while three mentioned only the presence of implants.…”

Invasive recurrence of serous borderline ovarian tumor as multifocal lymphadenopathy 25years after initial diagnosis

“…Aure et al (1971) displayed that the survival rate of these tumors dropped from 97% to 76% in the 5 to 20 year follow-up time. In addition, Leake et al (1992) found that the survival rate dropped from 97% to 89% during the same time frame.…”

Chemotherapy of borderline ovarian tumors

“…Néanmoins, ils continuent à décroître régulièrement après 5 ans. Ainsi, Leake rapporte des taux de survie à 5, 10, 15 et 20 ans de 97, 95, 92 et 89 % respectivement (tous stades confondus) [37]. Une minorité de patientes décèdent donc de leur maladie.…”

“…-Le pronostic global des TOLM est excellent (y compris pour les stades les plus évolués) [12,34,37,61,66] ;…”